| Literature DB >> 22439080 |
Abstract
Preeclampsia (PE) is one of the most common diseases worldwide, complicating ~5% of all pregnancies.Although no major progress has been achieved in the treatment of PE, our ability to identify women at highrisk has increased considerably during the past decade.The early identification of patients with an increased risk for preeclampsia is therefore one of the most important goals in obstetrics. Today, several markers may offer the potential to be used, most likely in a combinatory analysis, as predictors or diagnostic tools. We present here the current knowledge on the biology of preeclampsia and review several biochemical markers which may be used to monitor preeclampsia in a future, that, we hope, is not to distant from today.Entities:
Keywords: ADAM12; P-selectin; PAPP-A.; PP-13; PTX3; early diagnosis; effDNA; flt-1; hypertension; preeclampsia; sEng
Year: 2011 PMID: 22439080 PMCID: PMC3279168
Source DB: PubMed Journal: J Prenat Med ISSN: 1971-3282